Targeted Disruption of Chlamydia trachomatis Invasion by in Trans Expression of Dominant Negative Tarp Effectors

Christopher J Parrett1, Robert V Lenoci1, Brenda Nguyen1

  • 1Division of Immunology and Pathogenesis, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida Orlando, FL, USA.

Insights

Chlamydia trachomatis uses the Tarp protein to invade host cells. Genetic engineering of Tarp mutants reduced bacterial invasion, offering new therapeutic strategies against Chlamydia infections.

Area of Science:

  • Microbiology
  • Cell Biology
  • Pathogenesis

Background:

  • Chlamydia trachomatis invasion relies on the type III secreted effector protein, Tarp.
  • Previous studies used recombinant systems, limited by a lack of genetic tools for Chlamydia.

Purpose of the Study:

  • To investigate the in vivo role of Tarp in Chlamydia trachomatis invasion using dominant-negative mutant alleles.
  • To assess the impact of specific Tarp domain mutations on bacterial entry and intracellular growth.

Main Methods:

  • Engineered dominant-negative Tarp mutants in Chlamydia trachomatis.
  • Utilized epitope-tagged Tarp to confirm secretion into host cells during invasion.
  • Assessed invasion and growth of mutant strains in host cells.

Main Results:

  • Transformed Chlamydia trachomatis successfully produced and secreted epitope-tagged Tarp.
  • Mutants lacking the actin-binding or phosphorylation domains showed reduced host cell invasion.
  • Demonstrated in vivo evidence for Tarp's critical role in pathogenesis.

Conclusions:

  • Tarp is essential for efficient Chlamydia trachomatis invasion of host cells.
  • Engineered dominant-negative Tarp effectors can attenuate Chlamydia invasion, suggesting potential therapeutic applications.